Literature DB >> 27543158

Cytokine Release Syndrome after Haploidentical Stem Cell Transplantation.

David T Teachey1, Stephan A Grupp2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27543158     DOI： 10.1016/j.bbmt.2016.08.010

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  9 in total

Review 1.  Cellular therapy: Immune-related complications.

Authors:  Joseph H Oved; David M Barrett; David T Teachey
Journal:  Immunol Rev       Date:  2019-07       Impact factor: 12.988

2.  Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies.

Authors:  Tzu-Ting Chen; Ching-Chan Lin; Wen-Jyi Lo; Ching-Yun Hsieh; Ming-Yu Lien; Che-Hung Lin; Chen-Yuan Lin; Li-Yuan Bai; Chang-Fang Chiu; Su-Peng Yeh
Journal:  Int J Hematol       Date:  2022-02-28       Impact factor: 2.490

3.  Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes.

Authors:  Shannon R McCurdy; Stephen T Muth; Hua-Ling Tsai; Heather J Symons; Carol Ann Huff; William H Matsui; Ivan Borrello; Douglas E Gladstone; Lode J Swinnen; Kenneth R Cooke; Robert A Brodsky; Javier Bolaños-Meade; Richard F Ambinder; Ravi Varadhan; Leo Luznik; Richard J Jones; Maria P Bettinot; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2018-06-15       Impact factor: 5.742

4.  Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immune Deficiency Disorders in Children: Challenges and Outcome from a Tertiary Care Center in South India.

Authors:  Ramya Uppuluri; Meena Sivasankaran; Shivani Patel; Venkateswaran Vellaichamy Swaminathan; Kesavan Melarcode Ramanan; Nikila Ravichandran; Balasubramaniam Ramakrishnan; Indira Jayakumar; Lakshman Vaidhyanathan; Revathi Raj
Journal:  J Clin Immunol       Date:  2019-02-18       Impact factor: 8.317

5.  Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide.

Authors:  Jacopo Mariotti; Daniela Taurino; Fabrizio Marino; Stefania Bramanti; Barbara Sarina; Lucio Morabito; Chiara De Philippis; Clara Di Vito; Domenico Mavilio; Carmelo Carlo-Stella; Matteo Della Porta; Armando Santoro; Luca Castagna
Journal:  Cancer Med       Date:  2019-11-08       Impact factor: 4.452

Review 6.  Cytokine Release Syndrome and Associated Acute Toxicities in Pediatric Patients Undergoing Immune Effector Cell Therapy or Hematopoietic Cell Transplantation.

Authors:  Susanne H C Baumeister; Gopi S Mohan; Alaa Elhaddad; Leslie Lehmann
Journal:  Front Oncol       Date:  2022-03-24       Impact factor: 6.244

7.  Unrelated HLA mismatched microtransplantation in a patient with refractory secondary acute myeloid leukemia.

Authors:  Nathan Punwani; Noah Merin; Ann Mohrbacher; George Yaghmour; Allison Sano; Laleh Ramezani; Preet M Chaudhary; Giridharan Ramsingh
Journal:  Leuk Res Rep       Date:  2018-02-10

8.  Haploidentical Stem Cell Transplantation in Children with Benign Disorders: Improved Survival and Cost-Effective Care Over 15 Years from a Single Center in India.

Authors:  Ramya Uppuluri; Meena Sivasankaran; Shivani Patel; Venkateswaran Vellaichamy Swaminathan; Nikila Ravichandran; Kesavan Melarcode Ramanan; Lakshman Vaidhyanathan; Balasubramaniam Ramakrishnan; Indira Jayakumar; Revathi Raj
Journal:  Indian J Hematol Blood Transfus       Date:  2019-01-28       Impact factor: 0.900

9.  Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).

Authors:  Ibrahim Yakoub-Agha; Christian Chabannon; Peter Bader; Grzegorz W Basak; Halvard Bonig; Fabio Ciceri; Selim Corbacioglu; Rafael F Duarte; Hermann Einsele; Michael Hudecek; Marie José Kersten; Ulrike Köhl; Jürgen Kuball; Stephan Mielke; Mohamad Mohty; John Murray; Arnon Nagler; Stephen Robinson; Riccardo Saccardi; Fermin Sanchez-Guijo; John A Snowden; Micha Srour; Jan Styczynski; Alvaro Urbano-Ispizua; Patrick J Hayden; Nicolaus Kröger
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.